D
Dennis Deapen
Researcher at University of Southern California
Publications - 205
Citations - 16417
Dennis Deapen is an academic researcher from University of Southern California. The author has contributed to research in topics: Breast cancer & Population. The author has an hindex of 63, co-authored 200 publications receiving 13902 citations. Previous affiliations of Dennis Deapen include University of Michigan & University of California, San Francisco.
Papers
More filters
Journal ArticleDOI
The relationship between breast cancer and augmentation mammaplasty: an epidemiologic study.
TL;DR: A retrospective cohort study of 3111 women followed through various public and medical records for a total of 18,476 person-years suggests that many such women may have a reduced amount of breast tissue, but data on this are unavailable.
Journal ArticleDOI
An informed decision? Breast cancer patients and their knowledge about treatment.
Angela Fagerlin,Indu Lakhani,Paula M. Lantz,Nancy K. Janz,Monica Morrow,Kendra Schwartz,Dennis Deapen,Barbara Salem,Lihua Liu,Steven J. Katz +9 more
TL;DR: There is a need for fundamental changes in patient education to ensure that women are able to make informed decisions about their breast cancer treatment, including an increase in the use of decision aids and the speed at which treatment decisions are made.
Journal ArticleDOI
Childbearing and survival after breast carcinoma in young women
Beth A. Mueller,Beth A. Mueller,Michael S. Simon,Dennis Deapen,Aruna Kamineni,Aruna Kamineni,Kathleen E. Malone,Kathleen E. Malone,Janet R. Daling,Janet R. Daling +9 more
TL;DR: The authors measured relative mortality among young patients with breast carcinoma with and without births occurring after diagnosis, and found that childbearing after a diagnosis of breast carcin cancer affects survival.
Journal ArticleDOI
Relation of regimens of combined hormone replacement therapy to lobular, ductal, and other histologic types of breast carcinoma
Janet R. Daling,Janet R. Daling,Kathleen E. Malone,Kathleen E. Malone,David R. Doody,Lynda F. Voigt,Leslie Bernstein,Ralph J. Coates,Polly A. Marchbanks,Sandra A. Norman,Linda K. Weiss,Giske Ursin,Jesse A. Berlin,Ronald T. Burkman,Dennis Deapen,Suzanne G. Folger,Jill A. McDonald,Michael S. Simon,Brian L. Strom,Phyllis A. Wingo,Robert Spirtas +20 more
TL;DR: The use of combined (estrogen and progestin) hormone replacement therapy (CHRT) also has increased during the last decade and may account in part for the increase in invasive lobular breast carcinoma.
Journal ArticleDOI
Breast cancer: do specialists make a difference?
TL;DR: Treatment by a surgical oncologist resulted in a 33% reduction in the risk of death at 5 years of breast cancer treatment, and the effect of surgical specialization cannot be entirely attributed to volume effects.